Vivos Inc Provides Update on Initial Indication for Use for RadioGelTM Therapy
26. August 2020 09:30 ET
|
Vivos Inc.
Richland WA, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), We are excited to announce that based on the recommendation of our Medical Advisory Board, Vivos Inc has decided on treating...
Vivos Inc Reports Additional IsoPet Therapies
30. Juli 2020 07:00 ET
|
Vivos Inc.
Richland WA, July 30, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Interest in IsoPet therapy is increasing. Yesterday Vivos Inc treated “Mister Motto” a cat that the pet parents flew to the...
Vivos Inc Receives Grant of Protection for RadioGel™ Therapy in China
22. Juli 2020 07:00 ET
|
Vivos Inc.
Richland WA, July 22, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced it received the Grant of Protection for the Radiogel™ trademark application in China. The mark is now...
Vivos Inc Achieves Important Radiogel™ Development Milestones
24. Juni 2020 07:30 ET
|
Vivos Inc.
Richland WA, June 24, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced today significant progress in its efforts to advance RadioGel™ for human therapy. Animal testing at the...
Vivos Inc Expands its Intellectual Property Protection
10. Juni 2020 07:00 ET
|
Vivos Inc.
Richland WA, June 10, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos announced that is has submitted an international application based on its patent submittal last June. This is part of...
Vivos Inc Resumes IsoPet Animal Cancer Therapy
29. Mai 2020 07:00 ET
|
Vivos Inc.
Richland WA, May 29, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc Resumes IsoPet Animal Cancer Therapy After several months of virus-related stand-down IsoPet therapy has been...
University of Missouri Becomes the first Regional Clinic for Isopet® Therapy
06. Februar 2020 07:30 ET
|
Vivos Inc.
Richland WA, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos today announced that the University of Missouri College of Veterinary Medicine will be the first Isopet® regional...
Vivos Inc. Provides 2019 Recap and Outlines 2020 Objectives
13. Januar 2020 07:30 ET
|
Vivos Inc.
Richland WA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), provides 2019 recap and outlines future objectives. Vivos’ CEO, Dr. Mike Korenko stated, “as we begin 2020, I think it is...
Vivos Inc. Treats Additional Patients at its Pilot Clinic
03. Dezember 2019 07:00 ET
|
Vivos Inc.
Richland WA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced that two dogs with different cancer types were treated using Vivos Inc.’s Isopet® therapy on November 27 at...
Vivos Inc. Reports on IsoPet® Therapy at the Veterinary Cancer Society Annual Meeting
22. Oktober 2019 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos, Inc. key personnel attended the Veterinary Cancer Society annual meeting last week in Houston Texas which was attended...